Margaret T Davis1, Nicole DellaGioia2, David Matuskey2, Brian Harel3, Paul Maruff3, Robert H Pietrzak4, Irina Esterlis5. 1. Yale University School of Medicine, Departments of Psychiatry and Diagnostic Radiology, USA. Electronic address: margaret.t.davis@yale.edu. 2. Yale University School of Medicine, Departments of Psychiatry and Diagnostic Radiology, USA. 3. Cogstate, Ltd, Australia. 4. Yale University School of Medicine, Departments of Psychiatry and Diagnostic Radiology, USA; Cogstate, Ltd, Australia; US Department of Veterans Affairs National Center for Posttraumatic Stress Disorder, VA Connecticut Healthcare System, West Haven, CT, USA. 5. Yale University School of Medicine, Departments of Psychiatry and Diagnostic Radiology, USA; US Department of Veterans Affairs National Center for Posttraumatic Stress Disorder, VA Connecticut Healthcare System, West Haven, CT, USA.
Abstract
BACKGROUND: Cognitive deficits are common in individuals with major depressive disorder (MDD), and are associated with treatment non-responsiveness and poorer functional outcomes. Characterization of the nature and magnitude of deficits in this population has been limited in part by lack of brief, practical, and well-validated assessment measures. The goal of this study was to use a brief, practical, and repeatable computerized cognitive test battery from Cogstate to examine differences in cognitive functioning between individuals with MDD and healthy controls. METHODS: Forty participants (22 healthy controls (HCs), 18 with MDD) completed a battery of six cognitive measures, as well as measures of intellectual functioning (intellect) and depressive symptom severity. A multivariate analysis of covariance (MANCOVA) was conducted to compare cognitive test performance across groups while controlling for intellect. RESULTS: Individuals with MDD had lower full-scale IQ scores on average, and performed worse on measures of visual attention (d=1.04), verbal learning (d=1.22) and memory (d=1.22), and visuospatial problem solving (d=0.80) than HCs after adjustment for differences in intellect. Psychomotor speed, visual memory, and working memory did not differ between groups. CONCLUSIONS: Cogstate measures appear to be sensitive in assessing deficits in attention, verbal learning and memory, and executive function in individuals with MDD. Further research will be useful in establishing the utility of Cogstate measures for standard use in research and clinical practice.
BACKGROUND:Cognitive deficits are common in individuals with major depressive disorder (MDD), and are associated with treatment non-responsiveness and poorer functional outcomes. Characterization of the nature and magnitude of deficits in this population has been limited in part by lack of brief, practical, and well-validated assessment measures. The goal of this study was to use a brief, practical, and repeatable computerized cognitive test battery from Cogstate to examine differences in cognitive functioning between individuals with MDD and healthy controls. METHODS: Forty participants (22 healthy controls (HCs), 18 with MDD) completed a battery of six cognitive measures, as well as measures of intellectual functioning (intellect) and depressive symptom severity. A multivariate analysis of covariance (MANCOVA) was conducted to compare cognitive test performance across groups while controlling for intellect. RESULTS: Individuals with MDD had lower full-scale IQ scores on average, and performed worse on measures of visual attention (d=1.04), verbal learning (d=1.22) and memory (d=1.22), and visuospatial problem solving (d=0.80) than HCs after adjustment for differences in intellect. Psychomotor speed, visual memory, and working memory did not differ between groups. CONCLUSIONS:Cogstate measures appear to be sensitive in assessing deficits in attention, verbal learning and memory, and executive function in individuals with MDD. Further research will be useful in establishing the utility of Cogstate measures for standard use in research and clinical practice.
Authors: Anbupalam Thalamuthu; Natalie T Mills; Klaus Berger; Heike Minnerup; Dominik Grotegerd; Udo Dannlowski; Susanne Meinert; Nils Opel; Jonathan Repple; Marius Gruber; Igor Nenadić; Frederike Stein; Katharina Brosch; Tina Meller; Julia-Katharina Pfarr; Andreas J Forstner; Per Hoffmann; Markus M Nöthen; Stephanie Witt; Marcella Rietschel; Tilo Kircher; Mark Adams; Andrew M McIntosh; David J Porteous; Ian J Deary; Caroline Hayward; Archie Campbell; Hans Jörgen Grabe; Alexander Teumer; Georg Homuth; Sandra van der Auwera-Palitschka; K Oliver Schubert; Bernhard T Baune Journal: Mol Psychiatry Date: 2021-11-15 Impact factor: 15.992
Authors: Tamsyn E Van Rheenen; Kathryn E Lewandowski; Jessica M Lipschitz; Katherine E Burdick Journal: CNS Spectr Date: 2018-09-24 Impact factor: 3.790
Authors: Eric A Woodcock; Ansel T Hillmer; Christine M Sandiego; Paul Maruff; Richard E Carson; Kelly P Cosgrove; Robert H Pietrzak Journal: Brain Behav Immun Date: 2020-09-28 Impact factor: 7.217